Advances in treatment strategies for non–clear cell renal cell carcinoma
Year: 2024
Type: article
Abstract: Renal cell carcinoma is the sixth most commonly diagnosed cancer in men and the tenth in women, with clear cell renal cell carcinoma accounting for nearly 75% of cases. The remaining 25% consists of non–clear cell renal cell carcinoma, a diverse and less prevalent group. Although current treatments for clear cell types are well-defined, progress in treating non–clear cell renal cell carcinoma has been limited owing to its heterogeneity and rarity, relying primarily on findings from small-scale phase II clinical trials. This review examined recent advancements in the treatment of non–clear cell renal cell carcinoma, particularly in the areas of immunotherapy and targeted therapy.
Authors: Shangwei Li, Liangyou Gu, Xin Ma, Xu Zhang
Institution: Chinese PLA General Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4403812902